DNA hydroxymethylation is a long known modification of DNA, but has recently become a focus in epigenetic research. Mammalian DNA is enzymatically modified at the 5 th carbon position of cytosine (C) residues to 5-mC, predominately in the context of CpG dinucleotides. 5-mC is amenable to enzymatic oxidation to 5-hmC by the Tet family of enzymes, which are believed to be involved in development and disease. Currently, the biological role of 5-hmC is not fully understood, but is generating a lot of interest due to its potential as a biomarker. This is due to several groundbreaking studies identifying 5-hydroxymethylcytosine in mouse embryonic stem (ES) and neuronal cells.
The third part of the protocol is interrogation of the locus by PCR. As little as 20 ng of input DNA can be used. Amplification of the experimental (glucosylated and digested) and control (mock glucosylated and digested) target DNA with primers flanking a CCGG site of interest (100-200 bp) is performed. If the CpG site contains 5-hydroxymethylcytosine, a band is detected after glucosylation and digestion, but not in the nonglucosylated control reaction. Real time PCR will give an approximation of how much hydroxymethylcytosine is in this particular site.
In this experiment, we will analyze the 5-hydroxymethylcytosine amount in a mouse Babl/C brain sample by end point PCR.
Video Link
The video component of this article can be found at https://www. 
Discussion
There are several critical things to consider when setting up this experiment. First, it is important that the glucosylation of genomic DNA proceeds to completion. The sequence specificity of T4-BGT is not known, and it appears to have no choice for the substrate sequence. Therefore, in some cases, longer incubation times may be necessary. Second, MspI and HpaII digestion must be complete in order to avoid background signal. For these restriction enzymes, we recommend an incubation time of 4 hours, but longer incubations can be performed when incomplete cleavage is observed. Third, input DNA amount can be adjusted depending on availability, since 20 ngs of DNA can be used for end-point PCR.
Finally, we recommend the use of supplied control DNA which may be run in parallel with genomic DNA for 5-mC and 5-hmC quantification.
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